For ongoing education and resources, please visit RSNA’s Online Learning Center.
Content Areas (Codes):
The following Content Areas will be printed on the certificate for this course:
- Genitourinary Radiology
- Magnetic Resonance Imaging
- Molecular Imaging
Learning Objectives:
- Describe the evolving role of MRI in prostate cancer management.
- Discuss the recent updates on prostate MR protocol and interpretation.
- Employ tips that can help to improve image quality and optimize MR protocol.
- Illustrate the added value of some of the novel MR approaches on image interpretation.
- Review the mechanism of PSMA PET, and how it may be beneficial over existing PET radiotracers.
- Describe the various PSMA radiotracers and potential differences between the radiotracers.
- Explain the potential roles of PSMA PET in patients with biochemical recurrence.
- Explain the potential roles of PSMA PET in castration resistant prostate cancer.
- Recognize the need to certify readers, biopsy operators and accredit diagnostic units.
- Review innumerate the causes of variability in the ability of mpMRI to deliver patient benefits in men with negative and positive results.
- Describe international efforts regarding reader training, performance assessments and certification.
- Identify the magnitude of patient benefits attainable in an accredited environment.
- Outline the importance of quantitative prostate MRI in assessing prostate cancer heterogeneity.
- Review current status of radiomic assessment of the imaging phenotype and its correlation with biological features of prostate cancer.
- Review novel quantitative methods for assessing underlying prostate tissue microstructural features.
- Describe some good AI use cases for Prostate MRI.
- Describe the performance of AI computer aided diagnostic and prognostic tools for prostate MRI.
- Summarize some basic terms and steps related to convolutional neural networks and their development for prostate MRI.
- Review limitations of Prostate MRI for prostate cancer detection and staging.
- Describe the added Value of PET/MR for Prostate Cancer Detection and Staging.
- Illustrate Case-base review by demonstrating complementary role of PET and MRI.
This enduring material is estimated to take 1 hour to complete.
Start Date: 6/16/2021
End Date for CME Eligibility/Online Expiration Date: 6/15/2024
This educational activity was originally presented at the RSNA 2020 Annual Meeting and Scientific Assembly.
Faculty:
- Aytekin Oto, MD
- Thomas A. Hope, MD
- Anwar R. Padhani, MD, FRCR
- Fiona M. Fennessy, MD, PhD
- Masoom A. Haider, MD
- Nelly Tan, MD
Disclosure Statements:
The ACCME requires that the RSNA, as an accredited provider of CME, disclose the relevant financial relationships of the planners, faculty, and any other individuals in a position to control content of this activity. If there is a relevant financial relationship that has been disclosed please find it below:
- Matthew S. Davenport, MD: Royalties, Wolters Kluwer NV.
- Alexander R. Guimaraes, MD, PhD: Speakers Bureau, Siemens AG; Consultant, Takeda Pharmaceutical Company Limited, Merck & Co, Inc, Agfa-Gevaert Group, PAREXEL International Corporation.
- Ajay Gupta, MD: Support, Siemens AG, General Electric Company.
- Christopher P. Hess, MD, PhD: Research, Siemens AG; Consultant, General Electric Company.
- Vincent B. Ho, MD, MBA: Research collaboration, General Electric Company.
- Maxine S. Jochelson, MD: Speaker, General Electric Company; Consultant, Bayer AG.
- Jeffrey S. Klein, MD: Editor with royalties, Wolters Kluwer NV.
- Petra J. Lewis, MBBS: Committee Member, CairnSurgical.
- Katherine E. Maturen, MD: Royalties, Reed Elsevier, Wolters Kluwer NV.
- Matthew A. Mauro, MD: Board Member, Boston Scientific Corporation; Investor, Medtronic plc, Bayer AG.
- Christine O. Menias, MD: Royalties, Reed Elsevier.
- Charles E. Ray Jr, MD, PhD: Consultant, Medtronic plc; Editor with royalties, Thieme Medical Publishers, Inc.
- Evis Sala, MD, PhD: Co-founder, Cambridge AI Health; Speakers Bureau, GlaxoSmithKline plc.
- Jorge A. Soto, MD: Royalties, Reed Elsevier.
- Bachir Taouli, MD: Research Grant, Bayer AG, Takeda Pharmaceutical Company Limited, Regeneron Pharmaceuticals, Inc; Consultant, Alexion Pharmaceuticals, Inc, Bayer AG.
- Ioannis Vlahos, MRCP, FRCR: Director, Grayscale Ltd; Co-owner, Grayscale Ltd.
- Abbey Winant, MD: Spouse, Research Grant, Bristol-Myers Squibb Company, Novartis AG; Spouse, Research Consultant, Tango Therapeutics.
- Judy Yee, MD: Research Grant, EchoPixel, Inc, Koninklijke Philips NV, General Electric Company.
- Margarita L. Zuley, MD: Investigator, Hologic, Inc.
- Fiona M. Fennessy, MD, PhD: Consultant, VirtualScopics Inc.
- Thomas A. Hope, MD: Research Grant, Koninklijke Philips NV; Advisory Board, Ipsen SA; Consultant, Curium; Researcher, Advanced Accelerator Applications SA.
- Aytekin Oto, MD: Research Grant, Koninklijke Philips NV, Guerbet SA, Profound Medical Inc; Medical Advisory Board, Profound Medical Inc; Consultant, IBM Corporation; Founder, QMIS TBS Capital Group Corp; Co-owner, QMIS TBS Capital Group Corp.
- Anwar R. Padhani, MD, FRCR: Advisory Board, Siemens AG; Speakers Bureau, Siemens AG, Johnson & Johnson.
All other individuals in control of content have indicated that there are no relevant financial relationships with any commercial interests to be disclosed.
Accreditation and Designation Statements:
The Radiological Society of North America (RSNA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This enduring material can be applied towards the ABR MOC Part 2 requirement (CME).
To earn CME credit, participants must watch the full-length of the recording and complete the course evaluation.
The RSNA designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Price:
Non-member Rate: $50.00
Member Rate: $0.00
Refund / Exchange Policy:
RSNA will not issue any refunds or exchanges for online only versions of educational products or activities purchased online. Please review the entire product or activity description prior to purchase.
RSNA Disclaimer:
The opinions or views expressed in this activity are those of the presenters and do not necessarily reflect the opinions, recommendations or endorsement of the RSNA. Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product or device mentioned. Information presented, as well as publications, technologies, products and/or services discussed, are intended to inform the learner about the knowledge, techniques, and experiences of RSNA faculty who are willing to share such information with colleagues. The RSNA disclaims any and all liability for damages to any individual user for all claims which may result from the use of said information, publications, technologies, products and/or services, and events.